Company

Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc. is a US biopharmaceutical company developing targeted therapies for cancer patients.

About

Mirati Therapeutics develops targeted cancer therapies and is based in San Diego, US. Founded in 2013, the company has made three notable investments and is at the Seed stage. Its most recent add-on round raised EUR 208.70 mn, and its total amount raised is EUR 5800.00 mn. Charles Baum is the CEO.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in